
An expert in hematology/oncology comments on the importance of early detection and intervention of steroid-refractory chronic GvHD and considers approaches to switching treatments.

An expert in hematology/oncology comments on the importance of early detection and intervention of steroid-refractory chronic GvHD and considers approaches to switching treatments.

Yi-Bin Chen, MD, provides insight on common symptoms of GvHD (graft-versus-host disease), and shares tools for risk assessment and staging of the disease.